A U Sabitov

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Terapevticheskii arkhiv

This page only lists publications with an associated author ORCID identifier.

Publications

A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, O P Kovtun, P L Kuznetsov, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19]. Terapevticheskii arkhiv 96 (5) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19]. Terapevticheskii arkhiv 96 (3) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, O P Kovtun, P L Kuznetsov, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19]. Terapevticheskii arkhiv 96 (5) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, O P Kovtun, P L Kuznetsov, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19]. Terapevticheskii arkhiv 96 (5) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19]. Terapevticheskii arkhiv 96 (3) (2024)
A U Sabitov, O P Kovtun, E V Esaulenko, P V Sorokin
[A new approach to etiotropic therapy ARVI in children]. Terapevticheskii arkhiv 94 (11) (2022)
A U Sabitov, O P Kovtun, E V Esaulenko, P V Sorokin
[A new approach to etiotropic therapy ARVI in children]. Terapevticheskii arkhiv 94 (11) (2022)
A U Sabitov, O P Kovtun, E V Esaulenko, P V Sorokin
[A new approach to etiotropic therapy ARVI in children]. Terapevticheskii arkhiv 94 (11) (2022)
A U Sabitov, P V Sorokin, S Y Dashutina
[Experience of the preventive use of the drug Riamilovir in the foci of coronavirus infection (COVID-19)]. Terapevticheskii arkhiv 93 (4) (2021)